• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing functional performance in the mdx mouse model.评估杜氏肌营养不良症小鼠模型中的功能表现。
J Vis Exp. 2014 Mar 27(85):51303. doi: 10.3791/51303.
2
Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.营养不良性mdx小鼠肌肉的收缩效率:体内和体外对功能终点运动适应性的评估。
J Appl Physiol (1985). 2017 Apr 1;122(4):828-843. doi: 10.1152/japplphysiol.00776.2015. Epub 2017 Jan 5.
3
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.mdx和dko营养不良小鼠以及杜氏肌营养不良症患者骨骼肌中Notch信号通路的改变。
Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17.
4
Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.用人免疫球蛋白G治疗可改善杜氏肌营养不良小鼠模型的早期病程。
J Neurochem. 2016 Jan;136(2):351-62. doi: 10.1111/jnc.13269. Epub 2015 Aug 28.
5
Long-term human IgG treatment improves heart and muscle function in a mouse model of Duchenne muscular dystrophy.长期人 IgG 治疗可改善杜氏肌营养不良症小鼠模型的心脏和肌肉功能。
J Cachexia Sarcopenia Muscle. 2020 Aug;11(4):1018-1031. doi: 10.1002/jcsm.12569. Epub 2020 May 20.
6
A 3 months mild functional test regime does not affect disease parameters in young mdx mice.3 个月的轻度功能测试方案不会影响年轻 mdx 小鼠的疾病参数。
Neuromuscul Disord. 2010 Apr;20(4):273-80. doi: 10.1016/j.nmd.2010.02.004. Epub 2010 Mar 21.
7
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.致力于制定杜氏肌营养不良症mdx小鼠模型临床前测试的标准操作程序。
Neurobiol Dis. 2008 Jul;31(1):1-19. doi: 10.1016/j.nbd.2008.03.008. Epub 2008 Apr 9.
8
Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.N-乙酰半胱氨酸的临床前评估显示其在 Duchenne 肌营养不良症 mdx 小鼠模型中的副作用。
J Physiol. 2017 Dec 1;595(23):7093-7107. doi: 10.1113/JP274229. Epub 2017 Sep 30.
9
Noninvasive in vivo assessment of muscle impairment in the mdx mouse model--a comparison of two common wire hanging methods with two different results.体内非侵入性评估 mdx 小鼠模型中的肌肉损伤-两种常见悬线方法的比较,结果存在差异。
J Neurosci Methods. 2012 Jan 30;203(2):292-7. doi: 10.1016/j.jneumeth.2011.10.001. Epub 2011 Oct 12.
10
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy.评估 sGC 刺激剂 BAY-747 治疗杜氏肌营养不良症的潜力。
Int J Mol Sci. 2021 Jul 27;22(15):8016. doi: 10.3390/ijms22158016.

引用本文的文献

1
Cytoskeletal control in adult microglia is essential to restore neurodevelopmental synaptic and cognitive deficits.成年小胶质细胞中的细胞骨架控制对于恢复神经发育性突触和认知缺陷至关重要。
Sci Adv. 2025 Aug 29;11(35):eadw0128. doi: 10.1126/sciadv.adw0128.
2
MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration.微小RNA-33抑制通过增强骨骼肌再生改善肌肉萎缩症。
EMBO Mol Med. 2025 Jul 23. doi: 10.1038/s44321-025-00273-9.
3
The Competitive Loss of Cerebellar Granule and Purkinje Cells Driven by X-Linked Mosaicism in a Female Mouse Model of CASK-Related Disorders.在与CASK相关疾病的雌性小鼠模型中,由X连锁嵌合现象驱动的小脑颗粒细胞和浦肯野细胞的竞争性缺失
Cells. 2025 May 17;14(10):735. doi: 10.3390/cells14100735.
4
Anti-fibrotic, muscle-promoting antibody-drug conjugates for the improvement and treatment of DMD.用于改善和治疗杜氏肌营养不良症的抗纤维化、促进肌肉生长的抗体药物偶联物。
iScience. 2025 Apr 2;28(5):112335. doi: 10.1016/j.isci.2025.112335. eCollection 2025 May 16.
5
Pharmacology and macrophage modulation of HPGDS inhibitor PK007 demonstrate reduced disease severity in DMD-affected muscles of the mdx mouse model.HPGDS抑制剂PK007的药理学及巨噬细胞调节作用表明,mdx小鼠模型中受杜氏肌营养不良症影响的肌肉疾病严重程度降低。
Skelet Muscle. 2025 Apr 24;15(1):11. doi: 10.1186/s13395-025-00379-1.
6
TMEM65 regulates and is required for NCLX-dependent mitochondrial calcium efflux.跨膜蛋白65(TMEM65)调节并参与依赖于线粒体钙单向转运体反向转运蛋白(NCLX)的线粒体钙外流过程,且该过程需要TMEM65的参与。
Nat Metab. 2025 Apr;7(4):714-729. doi: 10.1038/s42255-025-01250-9. Epub 2025 Apr 8.
7
Becker muscular dystrophy mice showed site-specific decay of type IIa fibers with capillary change in skeletal muscle.贝克尔肌营养不良症小鼠表现出IIa型纤维的位点特异性衰退,并伴有骨骼肌中的毛细血管变化。
Elife. 2025 Mar 17;13:RP100665. doi: 10.7554/eLife.100665.
8
Combined effects of cannabidiol and Δ9-tetrahydrocannabinol alleviate migraine-like symptoms in mice.大麻二酚和Δ9-四氢大麻酚的联合作用可减轻小鼠的偏头痛样症状。
Cephalalgia. 2025 Feb;45(2):3331024251314487. doi: 10.1177/03331024251314487.
9
Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects.κ阿片受体激动剂U50,488的偏向类似物在疼痛及副作用临床前模型中的作用
Molecules. 2025 Jan 29;30(3):604. doi: 10.3390/molecules30030604.
10
Neurotherapeutic impact of vanillic acid and ibudilast on the cuprizone model of multiple sclerosis.香草酸和异丁司特对多发性硬化症铜螯合剂模型的神经治疗作用
Front Mol Neurosci. 2025 Jan 10;17:1503396. doi: 10.3389/fnmol.2024.1503396. eCollection 2024.

本文引用的文献

1
The effects of low levels of dystrophin on mouse muscle function and pathology.低水平肌营养不良蛋白对小鼠肌肉功能和病理学的影响。
PLoS One. 2012;7(2):e31937. doi: 10.1371/journal.pone.0031937. Epub 2012 Feb 16.
2
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector.使用经过翻译优化的 AAV 载体进行 1 期基因治疗杜氏肌营养不良症。
Mol Ther. 2012 Feb;20(2):443-55. doi: 10.1038/mt.2011.237. Epub 2011 Nov 8.
3
Noninvasive in vivo assessment of muscle impairment in the mdx mouse model--a comparison of two common wire hanging methods with two different results.体内非侵入性评估 mdx 小鼠模型中的肌肉损伤-两种常见悬线方法的比较,结果存在差异。
J Neurosci Methods. 2012 Jan 30;203(2):292-7. doi: 10.1016/j.jneumeth.2011.10.001. Epub 2011 Oct 12.
4
A single 30 min treadmill exercise session is suitable for 'proof-of concept studies' in adult mdx mice: a comparison of the early consequences of two different treadmill protocols.单次 30 分钟的跑步机运动对成年 mdx 小鼠的“概念验证研究”是合适的:两种不同跑步机方案的早期结果比较。
Neuromuscul Disord. 2012 Feb;22(2):170-82. doi: 10.1016/j.nmd.2011.07.008. Epub 2011 Aug 10.
5
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.系统注射磷酰胺吗啉寡聚物治疗杜氏肌营养不良症患者的外显子跳跃和肌营养不良蛋白修复:一项开放标签、2 期、剂量递增研究。
Lancet. 2011 Aug 13;378(9791):595-605. doi: 10.1016/S0140-6736(11)60756-3. Epub 2011 Jul 23.
6
Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice.增强翻译:mdx 小鼠中标准临床前实验的指南。
Neuromuscul Disord. 2012 Jan;22(1):43-9. doi: 10.1016/j.nmd.2011.04.012. Epub 2011 Jul 6.
7
Systemic administration of PRO051 in Duchenne's muscular dystrophy.普罗 051 用于杜氏肌营养不良的系统给药。
N Engl J Med. 2011 Apr 21;364(16):1513-22. doi: 10.1056/NEJMoa1011367. Epub 2011 Mar 23.
8
Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy.局部反义治疗后 mdx 小鼠不同程度肌营养不良蛋白恢复的肌肉力量的生理学特征。
Mol Ther. 2011 Jan;19(1):165-71. doi: 10.1038/mt.2010.213. Epub 2010 Oct 5.
9
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.庆大霉素诱导杜氏肌营养不良症中的终止密码子通读。
Ann Neurol. 2010 Jun;67(6):771-80. doi: 10.1002/ana.22024.
10
A 3 months mild functional test regime does not affect disease parameters in young mdx mice.3 个月的轻度功能测试方案不会影响年轻 mdx 小鼠的疾病参数。
Neuromuscul Disord. 2010 Apr;20(4):273-80. doi: 10.1016/j.nmd.2010.02.004. Epub 2010 Mar 21.

评估杜氏肌营养不良症小鼠模型中的功能表现。

Assessing functional performance in the mdx mouse model.

作者信息

Aartsma-Rus Annemieke, van Putten Maaike

机构信息

Department of Human Genetics, Leiden University Medical Center.

Department of Human Genetics, Leiden University Medical Center;

出版信息

J Vis Exp. 2014 Mar 27(85):51303. doi: 10.3791/51303.

DOI:10.3791/51303
PMID:24747372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4158772/
Abstract

Duchenne muscular dystrophy (DMD) is a severe and progressive muscle wasting disorder for which no cure is available. Nevertheless, several potential pharmaceutical compounds and gene therapy approaches have progressed into clinical trials. With improvement in muscle function being the most important end point in these trials, a lot of emphasis has been placed on setting up reliable, reproducible, and easy to perform functional tests to pre clinically assess muscle function, strength, condition, and coordination in the mdx mouse model for DMD. Both invasive and noninvasive tests are available. Tests that do not exacerbate the disease can be used to determine the natural history of the disease and the effects of therapeutic interventions (e.g. forelimb grip strength test, two different hanging tests using either a wire or a grid and rotarod running). Alternatively, forced treadmill running can be used to enhance disease progression and/or assess protective effects of therapeutic interventions on disease pathology. We here describe how to perform these most commonly used functional tests in a reliable and reproducible manner. Using these protocols based on standard operating procedures enables comparison of data between different laboratories.

摘要

杜兴氏肌肉营养不良症(DMD)是一种严重的进行性肌肉萎缩疾病,目前尚无治愈方法。然而,几种潜在的药物化合物和基因治疗方法已进入临床试验阶段。由于肌肉功能改善是这些试验中最重要的终点,因此在建立可靠、可重复且易于执行的功能测试方面投入了大量精力,以便在临床前评估DMD的mdx小鼠模型的肌肉功能、力量、状况和协调性。有侵入性和非侵入性测试可供选择。不会加重疾病的测试可用于确定疾病的自然史和治疗干预的效果(例如前肢握力测试、使用金属丝或网格的两种不同悬挂测试以及转棒试验)。或者,强迫跑步机跑步可用于加速疾病进展和/或评估治疗干预对疾病病理的保护作用。我们在此描述如何以可靠且可重复的方式进行这些最常用的功能测试。使用基于标准操作程序的这些方案能够比较不同实验室之间的数据。